Cognitive testing in the context of Alzheimer's Disease and dementia is crucial for early detection and monitoring of cognitive decline. These tests assess various cognitive functions such as memory, attention, language abilities, and problem-solving skills. They help clinicians establish a baseline of cognitive function, track changes over time, and differentiate between normal aging and pathological conditions like Alzheimer's.
Commonly used tests include the Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and Clock Drawing Test. These assessments provide valuable insights into a person's cognitive abilities and help in formulating personalized care plans. Early identification through cognitive testing allows for timely interventions, potentially slowing down cognitive decline and improving quality of life. Regular monitoring with these tests is essential for adapting care strategies as the disease progresses.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China